Mark Sheptoff Financial Planning’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$160 Buy
+12
New +$90 ﹤0.01% 503
2024
Q2
Sell
-61
Closed -$1.15K 440
2024
Q1
$1.15K Buy
61
+10
+20% +$172 ﹤0.01% 372
2023
Q4
$735 Hold
51
﹤0.01% 376
2023
Q3
$885 Hold
51
﹤0.01% 356
2023
Q2
$1.06K Hold
51
﹤0.01% 361
2023
Q1
$1.2K Hold
51
﹤0.01% 359
2022
Q4
$1.42K Buy
51
+47
+1,175% +$1.2K ﹤0.01% 362
2022
Q3
$0 Hold
4
﹤0.01% 392
2022
Q2
$0 Hold
4
﹤0.01% 415
2022
Q1
$0 Hold
4
﹤0.01% 472
2021
Q4
$0 Buy
+4
New +$130 ﹤0.01% 471

Other funds holding OGN

Mark Sheptoff Financial Planning's OGN Position: Q1 2026 in Review

Mark Sheptoff Financial Planning opened a new position in Organon & Co (OGN) in Q1 2026: 12 shares worth $160. The stake represents ﹤0.01% of the portfolio and ranks #503 among its holdings. This is a return to the name: Mark Sheptoff Financial Planning previously reported a position in OGN as recently as Q1 2024.

Mark Sheptoff Financial Planning first reported a position in OGN in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.42K in Q4 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Mark Sheptoff Financial Planning held 12 shares of Organon & Co worth $160 as of Q1 2026.
  • Organon & Co was a new Mark Sheptoff Financial Planning position in Q1 2026.
  • Organon & Co made up ﹤0.01% of Mark Sheptoff Financial Planning's portfolio in Q1 2026, its #503 holding.
  • Mark Sheptoff Financial Planning first reported a position in Organon & Co in Q4 2021 and has held it in 11 quarters since.
  • Mark Sheptoff Financial Planning's Organon & Co position peaked at $1.42K in Q4 2022.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.